Skip to content

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Qualitative Study on Detection and Treatment of Non-Small Cell Lung Cancer in Patients With a History of Alcohol or Substance Use Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07186699
Enrollment
45
Registered
2025-09-22
Start date
2025-09-29
Completion date
2028-09-12
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Non-Small Cell Carcinoma

Brief summary

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Detailed description

PRIMARY OBJECTIVE: I. To identify social facilitators and barriers to detection and treatment of NSCLC by interviewing a diverse group of patients at Keck, Los Angeles General Medical Center, and Norris Cancer Center with alcohol or substance use disorder history. OUTLINE: This is an observational study. Patients participate in a semi-structured interview and may participate in a follow-up focus group interview in which preliminary findings are shared and feedback is elicited on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

University of Southern California
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \* Adults ≥ 18 years of age * Histopathologic or cytologic diagnosis of NSCLC * Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy) * History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis * Ability to understand and the willingness to sign a written informed consent * English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent

Exclusion criteria

* Patients with cognitive disability unable to maintain 30-60 minute conversation

Design outcomes

Primary

MeasureTime frameDescription
Thematic saturationUp to 3 yearsWill use a Danaher framework to approach analyze interview data using NVivo software (NVivo version 11.0, QSR International). Each interview will be analyzed to identify broad themes.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBrooks V Udelsman

University of Southern California

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026